| Issue | Title | |
| Vol 23, No 1 (2016) | Eye-witnessing cancer—an ever-challenging experience | Abstract PDF HTML |
| S. Jurja | ||
| Vol 25, No 2 (2018) | Factors affecting radiotherapy prescribing patterns in the post-mastectomy setting | Abstract PDF HTML |
| T.A. Koulis, A. Dang, C. Speers, R.A. Olson | ||
| Vol 21, No 3 (2014) | Factors associated with breast cancer mortality after local recurrence | Abstract PDF HTML |
| R. Dent, A. Valentini, W. Hanna, E. Rawlinson, E. Rakovitch, P. Sun, S.A. Narod | ||
| Vol 21, No 4 (2014) | Factors associated with delayed time to adjuvant chemotherapy in stage iii colon cancer | Abstract PDF HTML |
| A. Chan, R. Woods, H. Kennecke, S. Gill | ||
| Vol 25, No 2 (2018) | Factors associated with imaging in patients with early breast cancer after initial treatment | Abstract PDF HTML |
| K. Enright, T. Desai, R. Sutradhar, A. Gonzalez, M. Powis, N. Taback, C.M. Booth, M.E. Trudeau, M.K. Krzyzanowska | ||
| Vol 21, No 4 (2014) | Factors associated with publication of randomized phase iii cancer trials in journals with a high impact factor | Abstract PDF HTML |
| P. Tang, G.R. Pond, S. Welch, E.X. Chen | ||
| Vol 26, No 1 (2019) | Factors associated with receipt of symptom screening in the year after cancer diagnosis in a universal health care system: a retrospective cohort study | Abstract PDF HTML |
| A. L. Mahar, L. E. Davis, L. D. Bubis, Q. Li, R. Sutradhar, N. G. Coburn, L. Barbera | ||
| Vol 20, No 1 (2013) | Factors associated with referral to medical oncology and subsequent use of adjuvant chemotherapy for non-small-cell lung cancer: a population-based study | Abstract PDF HTML |
| J. Kankesan, F.A. Shepherd, Y. Peng, G. Darling, G. Li, W. Kong, W.J. Mackillop, C.M. Booth | ||
| Vol 16, No 5 (2009) | Factors influencing mammography screening in Canada: An integrative review of the literature | Abstract PDF |
| P. Montgomery, K. Hanson, D. Bakker, M. Conlon | ||
| Vol 26, No 2 (2019) | Factors influencing surgical treatment decisions for breast cancer: a qualitative exploration of surgeon and patient perspectives | Abstract PDF HTML |
| E. Dicks, R. Roome, J. Chafe, E. Powell, F. McCrate, C. Simmonds, H. Etchegary | ||
| Vol 26, No 1 (2019) | Factors influencing the outcome of stereotactic radiosurgery in patients with five or more brain metastases | Abstract PDF HTML |
| E. Hamel-Perreault, D. Mathieu, L. Masson-Cote | ||
| Vol 20, No 3 (2013) | Factors influencing the quality of local management of ductal carcinoma in situ: a cohort study | Abstract PDF HTML |
| S.P. Krotneva, K.E. Reidel, A. Verma, N. Mayo, R. Tamblyn, A.N. Meguerditchian | ||
| Vol 26, No 1 (2019) | Factors influencing the use by radiation therapists of cancer symptom guides: a mixed-methods study | Abstract PDF HTML |
| C. Ludwig, J. Renaud, L. Barbera, M. Carley, C. Henry, L. Jolicoeur, C. Kuziemsky, A. Patry, D. Stacey | ||
| Vol 24, No 2 (2017) | Factors influencing treatment selection and survival in advanced lung cancer | Abstract PDF HTML |
| S. Tabchi, E. Kassouf, M. Florescu, M. Tehfe, N. Blais | ||
| Vol 18, No 6 (2011) | Factors related to the implementation and use of an innovation in cancer surgery | Abstract PDF HTML |
| R. Urquhart, J. Sargeant, G.A. Porter | ||
| Vol 20, No 3 (2013) | Fallopian tube removal: “STIC-ing” it to ovarian cancer: what is the utility of prophylactic tubal removal? | Abstract PDF HTML |
| T.J. Herzog, H.E. Dinkelspiel | ||
| Vol 26, No 3 (2019) | Fatal myocarditis and rhabdomyositis in a patient with stage IV melanoma treated with combined ipilimumab and nivolumab | Abstract PDF HTML |
| S. D. Saibil, L. Bonilla, H. Majeed, V. Sotov, D. Hogg, M. A. Chappell, M. Cybulsky, M. O. Butler | ||
| Vol 21, No 2 (2014) | FDG-PET in two cases of neurofibromatosis type 1 and atypical malignancies | Abstract PDF HTML |
| P. de Blank, K. Cole, L. Kersun, A. Green, J.J. Wilkes, J. Belasco, R. Bagatell, L.C. Bailey, M.J. Fisher | ||
| Vol 17, No 2 (2010) | Feasibility of administering zoledronic acid in palliative patients being cared for in the community: results of a pilot study | Abstract PDF |
| H. K. Marr, C. R. Stiles, M. A. Boyar, T. C. Braun, N. A. Hagen, C. Janzen, L. M. Whitten, J. L. Pereira | ||
| Vol 24, No 6 (2017) | Feasibility of assessing patient health benefits and incurred costs resulting from early dysphagia intervention during and immediately after chemoradiotherapy for head-and-neck cancer | Abstract PDF HTML |
| R. Martino, J. Ringash, L. Durkin, E. Greco, S. Hui Huang, W. Xu, C.J. Longo | ||
| Vol 17, No 2 (2010) | Febrile neutropenia rates with adjuvant docetaxel and cyclophosphamide chemotherapy in early breast cancer: discrepancy between published reports and community practice—a retrospective analysis | Abstract PDF |
| T. Vandenberg, J. Younus, S. Al-Khayyat | ||
| Vol 19, No 6 (2012) | Febrile neutropenia rates with adjuvant docetaxel and cyclophosphamide chemotherapy in early breast cancer: discrepancy between published reports and community practice—an updated analysis | Abstract PDF HTML |
| J. Younus, T. Vandenberg, M. Jawaid, M.A. Jawaid | ||
| Vol 23, No 4 (2016) | Fee-for-service cancer rehabilitation programs improve health-related quality of life | Abstract PDF HTML |
| A.A. Kirkham, S.E. Neil-Sztramko, J. Morgan, S. Hodson, S. Weller, T. McRae, K.L. Campbell | ||
| Vol 26, No 1 (2019) | Ferocious Beast | Abstract PDF HTML |
| N. A. Rutkowski | ||
| Vol 22, No 4 (2015) | Fertility preservation in reproductive-age women facing gonadotoxic treatments | Abstract PDF HTML |
| J. Roberts, R. Ronn, N. Tallon, H. Holzer | ||
| Vol 19, No 3 (2012) | Fertility risk discussions in young patients diagnosed with colorectal cancer | Abstract PDF HTML |
| A. Kumar, A. Merali, G.R. Pond, K. Zbuk | ||
| 2008: Presentations from the Integrating Wellness into Cancer Care Conference | Final Reports: Reports From Breakout Rooms | Abstract PPT Presentation |
| Presenter Presenter | ||
| Vol 19, No 1 (2012) | Fine-needle aspiration biopsy versus core-needle biopsy in diagnosing lung cancer: a systematic review | Abstract PDF HTML |
| X. Yao, M. M. Gomes, M. S. Tsao, C. J. Allen, W. Geddie, H. Sekhon | ||
| Vol 18, No 1 (2011) | First- and second-line therapy for metastatic urothelial carcinoma of the bladder | Abstract PDF HTML |
| F. A. Yafi, S. North, W. Kassouf | ||
| Vol 18, No 6 (2011) | First annual Canadian Cardiac Oncology Network conference | Abstract PDF HTML |
| S.F. Dent, N.A. Graham | ||
| Vol 25, No 4 (2018) | First case of sternum replacement with a bioceramic prosthesis after radio-induced sarcoma | Abstract PDF HTML |
| F. Bertin, E. Deluche, J. Tricard, A. Piccardo, E. Denes | ||
| Vol 16 (2009): Renal Cell Carcinoma Supplement | First-Line Therapy with Sunitinib in Advanced Renal Cell Carcinoma: Interpretation of the Overall Survival Data from ASCO 2008 | Abstract PDF |
| Lori Wood | ||
| Vol 19, No 3 (2012) | Fitness to drive in patients with brain tumours: the influence of mandatory reporting legislation on radiation oncologists in Canada | Abstract PDF HTML |
| A.V. Louie, D.P. D'Souza, D.A. Palma, G.S. Bauman, M. Lock, B. Fisher, N. Patil, G.B. Rodrigues | ||
| Vol 21, No 6 (2014) | Follicular dendritic cell sarcoma of the stomach: case report and review of the literature | Abstract PDF HTML |
| D. Shaw, R. Cuison, H. Ito | ||
| Vol 25, No 2 (2018) | Follow up | Abstract PDF HTML |
| A. Beswick | ||
| Vol 23, No 5 (2016) | Follow-up care for survivors of lymphoma who have received curative-intent treatment | Abstract PDF HTML |
| J. Sussman, N.P. Varela, M. Cheung, L. Hicks, D. Kraftcheck, J. Mandel, G. Fraser, L. Jimenez-Juan, A. Boudreau, S. Sajkowski, R. McQuillan | ||
| Vol 23, No 2 (2016) | Follow-up for cervical cancer: a Program in Evidence-Based Care systematic review and clinical practice guideline update | Abstract PDF HTML |
| L. Elit, E.B. Kennedy, A. Fyles, U. Metser | ||
| Vol 17, No 3 (2010) | Follow-up for women after treatment for cervical cancer | Abstract PDF |
| L. Elit, A. W. Fyles, T. K. Oliver, M. C. Devries-Aboud, M. Fung-Kee-Fung | ||
| Vol 23, No 5 (2016) | Follow-up of patients who are clinically disease-free after primary treatment for fallopian tube, primary peritoneal, or epithelial ovarian cancer: a Program in Evidence-Based Care guideline adaptation | Abstract PDF HTML |
| T. Le, E.B. Kennedy, J. Dodge, L. Elit | ||
| Vol 23, No 2 (2016) | Formal evaluation of PYNK: Breast Cancer Program for Young Women—the patient Perspective | Abstract PDF HTML |
| L. Cohen, J. Hamer, C. Helwig, K. Fergus, A. Kiss, R. Mandel, B. Dawson, A. Landsberg, K. Shein, N. Kay, E. Warner | ||
| Vol 16, No 2 (2009) | Fostering Healing Through Mindfulness In The Context of Medical Practice | Abstract PDF |
| Patricia Dobkin | ||
| Vol 22, No 5 (2015) | Found in translation: a medical student’s reflection on the emotional realities of translational cancer research | Abstract PDF HTML |
| R.J.M. Correa | ||
| Vol 15, No 6 (2008) | FRACTIONATED STEREOTACTIC RADIOTHERAPY IN THE TREATMENT OF PITUITARY MACROADENOMAS | Abstract PDF |
| Hamdy Sakr Elhateer, Thierry Muanza, David Roberge, Russell Ruo, Eman Eldebawy, Christine Lambert, Horacio Patrocinio, George Shenouda, Luis Souhami | ||
| Vol 26, No 3 (2019) | Framing of the opioid problem in cancer pain management in Canada | Abstract PDF HTML |
| R. Asthana, S. Goodall, J. Lau, C. Zimmermann, P. L. Diaz, A. B. Wan, E. Chow, C. De Angelis | ||
| Vol 26, No 3 (2019) | Fulfilling the potential of real-world evidence for lung cancer in Canada | Abstract PDF HTML |
| P. K. Cheema, S. Kuruvilla | ||
| Vol 19 (2012): Personalized Medicine in Metastatic NSCLC: a Canadian Perspective | Future of personalized medicine in non-small-cell lung cancer | Abstract PDF HTML |
| V. Hirsh | ||
| Vol 26, No 3 (2019) | Gaps and delays in survivorship care in the return-to-work pathway for survivors of breast cancer—a qualitative study | Abstract PDF HTML |
| K. Bilodeau, D. Tremblay, M.J. Durand | ||
| Vol 21, No 6 (2014) | Gemcitabine-based regimen for primary ovarian angiosarcoma with MYC amplification | Abstract PDF HTML |
| I. Yonezawa, M. Waki, Y. Tamura, R. Onoda, M. Narushima, T. Ishizuka, S. Tajima | ||
| Vol 25, No 4 (2018) | General practitioners in oncology: their valuable role throughout the cancer care trajectory | Abstract PDF HTML |
| G. Chaput, K. Broad | ||
| Vol 16, No 6 (2009) | Generalizability of toxicity data from oncology clinical trials to clinical practice: toxicity of irinotecan-based regimens in patients with metastatic colorectal cancer | Abstract PDF |
| V. Tam, S. Rask, T. Koru-Sengul, S. Dhesy-Thind | ||
| Vol 23, No 1 (2016) | Genetic polymorphisms of insulin-like growth factor 1 and insulin-like growth factor binding protein 3, xenoestrogen, phytoestrogen, and premenopausal breast cancer | Abstract PDF HTML |
| H. Li, M. Zhao, Q. Wang, L. Liu, Y.N. Qi, J.Y. Liu | ||
| Vol 20, No 2 (2013) | Genetically modified foods, cancer and diet: myths and reality | Details PDF HTML |
| L.Z.G. Touyz | ||
| Vol 20, No 5 (2013) | Genitourinary small-cell carcinoma: a single-institution experience | Abstract PDF HTML |
| N. Pervez, F. El-Gehani, K. Joseph, A. Dechaphunkul, M. Kamal, D. Pertschy, P. Venner, S. Ghosh, S. North | ||
| Vol 16, No 1 (2009) | Genomancy: predicting tumor response to cancer therapy | Abstract PDF |
| Dan Theodorescu, P.D. Williams, J.K. Lee | ||
| Vol 21, No 2 (2014) | Geographic disparities in surgery for breast and rectal cancer in Canada | Abstract PDF HTML |
| T. Forte, G. Porter, R. Rahal, K. DeCaria, J. Niu, H. Bryant, the System Performance Steering Committee and Technical Working Group | ||
| Vol 25, No 5 (2018) | Geographic variation in surgical practice patterns and outcomes for resected nonmetastatic gastric cancer in Ontario | Abstract PDF HTML |
| A. L. Mahar, A. El-Sedfy, M. Dixon, M. Siddiqui, M. Elmi, A. Ritter, J. Vasilevska-Ristovska, Y. Jeong, L. Helyer, C. Law, B. Zagorski, N. G. Coburn | ||
| Vol 14, No 5 (2007) | Gliadel® Wafers in the Treatment of Malignant Glioma: A Systematic Review | Details PDF |
| James Perry, Alexandra Chambers, Karen Spithoff, Normand Laperriere | ||
| Vol 25, No 3 (2018) | Glove and instrument changing to prevent tumour seeding in cancer surgery: a survey of surgeons’ beliefs and practices | Abstract PDF HTML SUPPLEMENTAL MATERIAL |
| D. Berger-Richardson, R.S. Xu, R.A. Gladdy, J.A. McCart, A. Govindarajan, C.J. Swallow | ||
| Vol 20, No 6 (2013) | Glucocorticoid-induced hyperglycemia is prevalent and unpredictable for patients undergoing cancer therapy: an observational cohort study | Abstract PDF HTML |
| D. Harris, A. Barts, J. Connors, M. Dahl, T. Elliott, J. Kong, T. Keane, D. Thompson, S. Stafford, E. Ur, S. Sirrs | ||
| Going Beyond Efficacy | Going Beyond Efficacy: Strategies for Cancer Pain Management | Details PDF |
| Jeff Myers, Niren Shetty | ||
| Vol 24, No 1 (2017) | Guideline for radiotherapy with curative intent in patients with early stage, medically inoperable, non-small cell lung cancer | Abstract PDF HTML |
| C.B. Falkson, E.T. Vella, E. Yu, M. El-Mallah, R. Mackenzie, P.M. Ellis, Y.C. Ung | ||
| Vol 13, No 2 (2006) | Guidelines for the diagnosis and management of carcinoid tumours, part 1: the gastrointestinal tract. A statement from a Canadian National Carcinoid Expert Group | Details PDF |
| Jean Maroun, Kocha Walter, Larry Kvols, Georg Bjarnason, Eric Chen, Colin Germond, Sherif Hanna, Pierre Poitras, Daniel Rayson, Robert Reid, Juan Rivera, Andre Roy, Amil Shah, Lucas Sideris, Lillian Siu, Ralph Wong | ||
| Vol 22, No 2 (2015) | Guidelines on the use of cytoreductive surgery and hyperthermic intraperitoneal chemotherapy in patients with peritoneal surface malignancy arising from colorectal or appendiceal neoplasms | Abstract PDF HTML |
| P. Dubé, L. Sideris, C. Law, L. Mack, E. Haase, C. Giacomantonio, A. Govindarajan, M.K. Krzyzanowska, P. Major, Y. McConnell, W. Temple, R. Younan, J.A. McCart | ||
| Vol 23, No 2 (2016) | Guideposts for quests in the realm of oncology careers | Abstract PDF HTML |
| S. Snow, T. Younis | ||
| Vol 25, No 3 (2018) | Harmonization of PD-L1 testing in oncology: a Canadian pathology perspective | Abstract PDF HTML SUPPLEMENTAL MATERIAL |
| D.N. Ionescu, M.R. Downes, A. Christofides, M.S. Tsao | ||
| Vol 22, No 5 (2015) | Has screening mammography become obsolete? | Abstract PDF HTML |
| M.E. Costanza | ||
| Vol 17, No 1 (2010) | Has the practice of radiation oncology for locally advanced and metastatic non-small-cell lung cancer changed in Canada? | Abstract PDF |
| K. Han, A. Bezjak, W. Xu, G. Kane | ||
| Vol 22, No 3 (2015) | Have we given up on a cure for ovarian cancer? | Abstract PDF HTML |
| S.A. Narod | ||
| Vol 15, No 4 (2008) | Healing and Survivorship: What Makes a Difference? | Abstract PDF |
| Martin R. Chasen, Hillel D. Braude | ||
| Vol 21, No 3 (2014) | Health care costs for prostate cancer patients receiving androgen deprivation therapy: treatment and adverse events | Abstract PDF HTML |
| M.D. Krahn, K.E. Bremner, J. Luo, S.M.H. Alibhai | ||
| Vol 21, No 5 (2014) | Health care delivery for head-and-neck cancer patients in Alberta: a practice guideline | Abstract PDF HTML |
| J.R. Harris, H. Lau, B.V. Surgeoner, N. Chua, W. Dobrovolsky, J.C. Dort, E. Kalaydjian, M. Nesbitt, R.A. Scrimger, H. Seikaly, D. Skarsgard, M.A. Webster, Members of the Alberta Provincial Head and Neck Tumour Team | ||
| Vol 21, No 5 (2014) | Health care, health caring, and the culture of medicine | Abstract PDF HTML |
| H.M. Chochinov | ||
| Vol 18, No 5 (2011) | Health care strategies to promote earlier presentation of symptomatic breast cancer: perspectives of women and family physicians | Abstract PDF HTML |
| R. Heisey, M. Clemons, L. Granek, K. Fergus, S. Hum, B. Lord, D. R. McCready, B. Fitzgerald | ||
| Vol 15, No 1 (2008) | Health management program: factors influencing completion of therapy with high-dose interferon alfa-2b for high-risk melanoma | Abstract PDF |
| Jean-François Pouliot, Nancy Levesque, K Mitchinson, Debbie Lawrie, Leslie Fedorak, D MacDonald | ||
| Vol 21, No 6 (2014) | Health system costs for stage-specific breast cancer: a population-based approach | Abstract PDF HTML |
| N. Mittmann, J.M. Porter, J. Rangrej, S.J. Seung, N. Liu, R. Saskin, M.C. Cheung, N.B. Leighl, J.S. Hoch, M. Trudeau, W.K. Evans, K.N. Dainty, C. DeAngelis, C.C. Earle | ||
| Vol 20, No 5 (2013) | Helicobacter pylori infection predicts favorable outcome in patients with gastric cancer | Abstract PDF HTML |
| F. Wang, G.P. Sun, Y.F. Zou, F. Zhong, T. Ma, X.Q. Li, D. Wu | ||
| Vol 23, No 2 (2016) | Hematogones: a sensitive prognostic factor for Chinese adult patients with acute myeloid leukemia | Abstract PDF HTML |
| L. Li, R. Fu, T. Zhang, X. Xie, J. Liu, J. Tao, J. Song, H. Liu, W. Zhang, W. Lu, Z. Shao | ||
| Vol 21, No 1 (2014) | Hepatic arterial infusion pump chemotherapy for colorectal liver metastases: an old technology in a new era | Abstract PDF HTML |
| Y.J. Ko, P.J. Karanicolas | ||
| Vol 21, No 1 (2014) | Hepatic arterial infusion pump chemotherapy in the management of colorectal liver metastases: expert consensus statement | Abstract PDF HTML |
| P.J. Karanicolas, P. Metrakos, K. Chan, T. Asmis, E. Chen, T.P. Kingham, N. Kemeny, G. Porter, R.C. Fields, J. Pingpank, E. Dixon, A. Wei, S. Cleary, G. Zogopoulos, C. Dey, M. D'Angelica, Y. Fong, S. Dowden, Y.J. Ko | ||
| Vol 14, No 2 (2007) | Hepatocyte Growth Factor and the HGF Receptor Signalling Complex as Targets in Cancer Therapies | Details PDF |
| Wen G Jiang | ||
| Vol 23, No 1 (2016) | Hepcidin and ferroportin expression in breast cancer tissue and serum and their relationship with anemia | Abstract PDF HTML |
| X. Pan, Y. Lu, X. Cheng, J. Wang | ||
| Vol 20, No 5 (2013) | Hereditary colorectal cancer registries in Canada: report from the Colorectal Cancer Association of Canada consensus meeting; Montreal, Quebec; October 28, 2011 | Abstract PDF HTML |
| H. Rothenmund, H. Singh, B. Candas, B. Chodirker, K. Serfas, M. Aronson, S. Holter, A. Volenik, J. Green, E. Dicks, M.O. Woods, D. Gilchrist, R. Gryfe, Z. Cohen, W.D. Foulkes | ||
| Vol 23, No 4 (2016) | High-grade glioma management and response assessment—recent advances and current challenges | Abstract PDF HTML |
| M.N. Khan, A.M. Sharma, M. Pitz, S.K. Loewen, H. Quon, A. Poulin, M. Essig | ||
| Vol 16, No 3 (2009) | High-grade hyperinvasive sarcomatoid urothelial bladder carcinoma demonstrating complete response to bladder-preserving chemoradiation | Details PDF |
| Jonathan Brett Wallach, Beverly Wang, Nicholas Sanfilippo | ||
| Vol 20, No 5 (2013) | "His Turn" | Abstract PDF HTML |
| A.C. Swan | ||
| Vol 22, No 3 (2015) | Histologic classification of non-small-cell lung cancer over time: reducing the rates of not-otherwise-specified | Abstract PDF HTML |
| C. Ho, K.M. Tong, K. Ramsden, D.N. Ionescu, J. Laskin | ||
| Vol 15, No 5 (2008) | Histone Deacetylase Inhibitors as Novel Anti-Cancer Therapeutics | Details PDF |
| Donald R. Walkinshaw, Xiang-Jiao Yang | ||
| Vol 25, No 1 (2018) | HIV-positive MSM’s knowledge of HPV and anal cancer self-sampling: A scoping review | Abstract PDF HTML |
| M.K.L. Poon, J.P.H. Wong, A.T.W. Li, M. Manuba, A. Bisignano, M. Owino, M. Vahabi | ||
| Vol 14, No 4 (2007) | Homeopathy for cancer? | Details PDF |
| Edzard Ernst | ||
| Vol 14, No 6 (2007) | Homeopathy, fundamentalism, and the memory of water | Details PDF |
| Lionel Robert Milgrom | ||
| Vol 14, No 4 (2007) | Homeopathy: Does A Teaspoon of Honey Help the Medicine Go Down? | Details PDF |
| Stephen Sagar | ||
| Vol 21, No 3 (2014) | Hormonal manipulation with letrozole in the treatment of metastatic malignant PEComa | Abstract PDF HTML |
| P. Le, A. Garg, G. Brandao, A. Abu-Sanad, L. Panasci | ||
| Vol 25 (2018): Advances in Breast and Lung Cancers for the Community Oncologist | Hormone receptor–positive, HER2-negative metastatic breast cancer: redrawing the lines | Abstract PDF HTML |
| A. Matutino, A.A. Joy, C. Brezden-Masley, S. Chia, S. Verma | ||
| Vol 16, No 3 (2009) | Hormone replacement therapy and outcome for women with non-small cell lung cancer: can an association be confirmed? | Abstract PDF |
| Omodele Ayeni, Andrew Robinson | ||
| Vol 25, No 3 (2018) | How can we better help cancer patients quit smoking? The London Regional Cancer Program experience with smoking cessation | Abstract PDF HTML |
| S. M. Davidson, R.G. Boldt, A.V. Louie | ||
| Vol 24, No 2 (2017) | How different is cancer control across Canada? Comparing performance indicators for prevention, screening, diagnosis, and treatment | Abstract PDF HTML |
| R. Rahal, J. Chadder, K. DeCaria, G. Lockwood, H. Bryant, in collaboration with the System Performance Steering Committee and the Technical Working Group | ||
| Vol 15 (2008): Supplement - Integrative Oncology: A Canadian and International Perspective | How do we evaluate outcome in an integrative oncology program? | Abstract PDF |
| Stephen Sagar | ||
| Vol 17, No 3 (2010) | How effective is video consultation in clinical oncology? A systematic review | Abstract PDF |
| C. Kitamura, L. Zurawel-Balaura, R. K.S. Wong | ||
| Vol 21, No 3 (2014) | How has acute oncology improved care for patients? | Abstract PDF HTML |
| V. Navani | ||
| Vol 13, No 6 (2006) | HOW SHOULD WE DESCRIBE THE BENEFITS OF PALLIATIVE RADIOTHERAPY? | Abstract PDF |
| Rajiv S Samant, Tara L Tucker | ||
| 601 - 700 of 1627 Items | << < 2 3 4 5 6 7 8 9 10 11 > >> | |
User
Current Oncology is published by:
Endorsed publication of the Canadian Association of Psychosocial Oncology (CAPO)
